Martin Landray
@MartinLandray
Physician, epidemiologist & clinical trialist: http://recoverytrial.net @oxford_ndph. Lead, Good Clinical Trials Collaborative http://www.goodtrials.org. CEO http://www.Protas.co.uk
Watch #RECOVERY Co-Chief Investigators @PeterHorby and @MartinLandray discuss the trial and hear from Elaine, one of the more than 50,000 people who have participated in the RECOVERY trial to date 🎥
Thank you so much for joining Team Crisis, Martin ❤️ We'll be cheering you on all the way 🏃♂️
Something new for me: I am taking part in the Hampton Court Half Marathon on Sunday 23rd March and raising money for @crisis_uk a national charity addressing homelessness. Your donations would make a big difference. Thank you! justgiving.com/page/martin-la…
The #RECOVERYTrial has been shortlisted for a NIHR Impact Prize. Read more below 👇 @MartinLandray @PeterHorby
The wait is over! The NIHR Impact Prizes shortlist is here.🎉 Out of 136 outstanding entries, we’ll be celebrating a handful of researchers & teams whose work is transforming lives & driving economic growth.🌟 Winners will be revealed on 20 March. Stay tuned! Who are the…
Professor Sir @MartinLandray, Joint Chief Investigator for RECOVERY, explains what makes the #RECOVERYTrial appropriate for investigating flu treatments below.😷 @OxfordMedSci @UniofOxford @NDMOxford
See what Sir @PeterHorby, Moh Family Foundation Professor of Emerging Infections and Global Health, and Joint Chief Investigator for the #RECOVERYTrial said below: @OxfordMedSci @PSIOxford @NDMOxford @UniofOxford
Participating in #clinicaltrials is a great way to further our scientific knowledge and help find effective treatments for severe flu. To find out more about participating in the RECOVERY trial, visit our website 👉 buff.ly/2W03aXM
Controversial COVID study that promoted unproven treatment retracted after four-year saga nature.com/articles/d4158… Ironic that the co-authors complain they were “victims of cyber-harassment” - they should try being on the receiving end of HCQ believers, including Raoult himself.
Extraordinary: Raoult’s damaging paper on hydroxychloroquine for COVID-19 finally retracted. So grateful to all the people who helped with the RECOVERY trial, allowing us to debunk the myth of hydroxychloroquine for severe COVID-19 science.org/content/articl…
Influenza going up in the UK. For those involved in the RECOVERY trial of influenza treatments - please try to enrol patients. If this season is short and sharp, we will have a limited time window for recruitment.
Just heading home from Faster Cures conference in DC. Great speakers, including many past & present federal health agency leaders and politicians. But quote of the week goes to Ashwin Vasan (ex-Health Commissioner, New York) @ashvasnyc : “Health is Freedom!” Well said.
EMPA-KIDNEY post-trial f-up has revealed helpful findings on #SGLT2i in #CKD. We hope residual uncertainties r resolving & more pts r treated early & long-term. Deep gratitude to 1600+ collaborators & 6609 pts.#KidneyWk @NatalieStaplin @RichardHaynes3 @MartinLandray @Oxford_NDPH
Presented at #KidneyWk: Two years of empagliflozin slowed kidney disease progression or cardiovascular death. In a post-trial study, empagliflozin had additional cardiorenal benefits after discontinuation. Full post-trial study results: nej.md/3NE3W7K
A brilliant opportunity to join @wellcometrust as Head of Global Government Relations — working with the wonderful @meganchallis and team. linkedin.com/jobs/view/4048…
Wonderful, inspiring visit to @AllenInstitute today. Great to discuss a big leap forward in the development and evaluation of new treatments, particularly for dementia All at unprecedented scale, speed and affordability. #OpenScience #TeamScience #ClinicalTrials
